The Glioblastoma Research Organization (GBMRO) announces its largest donation to date, $80,000, to fund Project DeLaRosa in partnership with Children's National Hospital. The research, "Longitudinal Biopsy for Evaluation of Treatment Response and Tumor Immune-microenvironment for Diffuse Midline Glioma," targets pediatric tumors, aiming to revolutionize the understanding and treatment of aggressive central nervous system (CNS) tumors.

The Glioblastoma Research Organization (GBMRO) has launched its latest initiative, Project Liam, which aims to fund research focused on pediatric brain cancer. Project Liam marks the nonprofit's fifth fully-funded glioblastoma research project, and its first in partnership with Children's Hospital Los Angeles. This new pediatric brain cancer research funding initiative is a significant step towards advancing the understanding and treatment of this devastating disease in children.

The median glioblastoma survival rate for adults is 14.6 months, making it one of the deadliest forms of brain cancer, largely occurring in older adults. The median age at diagnosis is 65, and patient prognosis is known to decline with increased age. Christopher Hine, Ph.D., a researcher at Cleveland Clinic, has a theory that could explain why.